T‐cell redirecting bispecific antibodies in multiple myeloma: Current landscape and future directions

T‐cell redirecting bispecific antibodies in multiple myeloma: Current landscape and future directions

Abstract T‐cell engaging bispecific antibodies (BsAbs) have substantial activity in heavily pretreated patients with multiple myeloma (MM). The overall response rate obtained with B‐cell maturation antigen (BCMA)‐targeting BsAbs is approximately 60%–70%, including a high proportion of patients achie...

Full description

Bibliographic Details
Main Authors: Chloe O'Neill, Niels W. C. J. van deDonk
Format: Article
Language:English
Published: Wiley 2023-08-01
Series:eJHaem
Subjects:
BCMA
FcRH5
GPRC5D
immunotherapy
multiple myeloma
T‐cell redirecting bispecific antibody
Online Access:https://doi.org/10.1002/jha2.729

Similar Items

Similar Items